As reported by GenomeWeb News, last week a jury has determined that Stratagene's quantitative PCR and RT-PCR reagents using its FullVelocity technology infringe two patents held by Third Wave Technologies as part of its Invader technology.
Stratagene said that it was informed that the jury had awarded Third Wave $5.29 million in damages. The company said that the jury's verdict and the damages awarded were not supported by the facts of the case and, as a result, it will appeal the decision.
Stratagene also said that it has served Third Wave with a patent infringement suit filed in May. That suit alleges Third Wave has infringed certain Stratagene technology related to the quantitative detection of nucleic acids, and seeks monetary damages and a permanent injunction against continued infringement.